2017
DOI: 10.7861/clinmedicine.17-1-93
|View full text |Cite
|
Sign up to set email alerts
|

Screening for dementia: single yes/no question or Likert scale?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 4 publications
1
10
1
Order By: Relevance
“…As the study setting, a dedicated memory disorders clinic, was anticipated to have a high prevalence of cognitive impairment, it was surprising that so many patients answered “No” to the Dementia CQUIN screening question. Indeed, this study observed a lower self‐rating of memory impairment using the yes/no screening question (60%) than using the Likert scale (90%), the reverse of the findings in epilepsy clinic‐based patient cohorts …”
Section: Measures Of Discrimination For Diagnosis Of Cognitive Impaircontrasting
confidence: 41%
See 1 more Smart Citation
“…As the study setting, a dedicated memory disorders clinic, was anticipated to have a high prevalence of cognitive impairment, it was surprising that so many patients answered “No” to the Dementia CQUIN screening question. Indeed, this study observed a lower self‐rating of memory impairment using the yes/no screening question (60%) than using the Likert scale (90%), the reverse of the findings in epilepsy clinic‐based patient cohorts …”
Section: Measures Of Discrimination For Diagnosis Of Cognitive Impaircontrasting
confidence: 41%
“…A pragmatic diagnostic test accuracy study was performed examining two simple tests which may be judged to access the construct of metamemory (i.e., subjective memory judgments): the Dementia Commissioning for Quality and Innovation (Dementia CQUIN) screening question (“Have you been more forgetful in the past 12 months to the extent that it has significantly affected your life?”) and a five‐point SMC Likert scale (“In general, how would you rate your memory?”: 1 = poor; 2 = fair; 3 = good; 4 = very good; 5 = excellent; ratings of either fair or poor defined as SMC+). Prior experience has been gained with administration of both these tests . A standard patient assessment cognitive screening instrument, the Mini‐Addenbrooke's Cognitive Examination (MACE), was also administered, using the cut‐off for cognitive impairment from the index study (MACE ≤25/30).…”
Section: Measures Of Discrimination For Diagnosis Of Cognitive Impairmentioning
confidence: 99%
“…The demographic data were similar with respect to age in the prior study (SMC+ 42.7 ± 15.1 years, SMC-42.0 ± 16.3) [2]. However, the possible association of disease duration with subjective memory complaint which was previously noted [2,4] was not observed in this cohort.…”
Section: Discussionsupporting
confidence: 74%
“…Study shortcomings include the small size of the cohort: the number of SMC+ patients was unexpectedly lower than anticipated (6%, vs. 20% in a previous study [2]) the reasons for which are not immediately apparent. The demographic data were similar with respect to age in the prior study (SMC+ 42.7 ± 15.1 years, SMC-42.0 ± 16.3) [2]. However, the possible association of disease duration with subjective memory complaint which was previously noted [2,4] was not observed in this cohort.…”
Section: Discussionmentioning
confidence: 71%
See 1 more Smart Citation